LEVIN ARTHUR A
Director · 4 filings · Latest: Jun 3, 2026
Avidity Biosciences, Inc.
Stoke Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
STOK | LEVIN ARTHUR A | Director | Mar 13, 2026 | Sale | $36.80 | 605 | $22.3K | 4,237 | |
STOK | ARTHUR A LEVIN | — | Mar 13, 2026 | Proposed Sale | $36.48 | 605 | $22.1K | — | |
RNA | LEVIN ARTHUR A | Director | Jan 21, 2026 | Sale | $72.45 | 1,758 | $127.4K | 16,562 | |
RNA | ARTHUR LEVIN | — | Aug 6, 2025 | Proposed Sale | $38.26 | 107,500 | $4.1M | — | |
RNA | ARTHUR A LEVIN | — | Oct 21, 2024 | Proposed Sale | $50.45 | 8,323 | $419.9K | — | |
RNA | LEVIN ARTHUR A | — | Oct 16, 2024 | Proposed Sale | $46.60 | 22,500 | $1.0M | — |